Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • ELCC 2018

    The 8th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland

    Presentation Date(s):  
    • Apr 11 - 14, 2018
    • Total Presentations: 407

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    Industry Satellite Symposium 4

    • Type: Industry Satellite Symposium
    • Presentations: 0
    • Coordinates: 4/12/2018, 18:40 - 19:40, Room A
  • +

    Industry Satellite Symposium 5

    • Type: Industry Satellite Symposium
    • Presentations: 0
    • Coordinates: 4/12/2018, 18:40 - 19:40, Room C
  • +

    Combining radiation with non-chemotherapy agents

    • Type: Multidisciplinary Interactive Session (MIS)
    • Presentations: 3
    • Moderators:N. Andratschke
    • Coordinates: 4/13/2018, 08:00 - 08:50, Room A
    • +

      Combining radiotherapy with TKIs in oligo-progressive oncogene addicted NSCLC

      08:00 - 08:15  |  Presenter: N. Andratschke

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Combining radiotherapy with immune-checkpoint inhibitors

      08:15 - 08:30  |  Presenter: A. Naing

      • Abstract

      No abstract available for this presentation

    • +

      Discussion

      08:30 - 08:50

      • Abstract

      No abstract available for this presentation

  • +

    Liquid biopsy at the initial diagnosis and during monitoring

    • Type: Multidisciplinary Interactive Session (MIS)
    • Presentations: 3
    • Moderators:M. Denis
    • Coordinates: 4/13/2018, 08:00 - 08:50, Room W
    • +

      Which technology can we use? CTCs vs ctDNA

      08:00 - 08:15  |  Presenter: M. Denis

      • Abstract

      No abstract available for this presentation

    • +

      Diagnosis and monitoring with liquid biopsy for targeted treatment

      08:15 - 08:30  |  Presenter: F. Barlesi

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Discussion

      08:30 - 08:50

      • Abstract

      No abstract available for this presentation

  • +

    Immunotherapy combinations

    • Type: Educational session
    • Presentations: 5
    • Moderators:S. Antonia
    • Coordinates: 4/13/2018, 09:00 - 10:30, Room B
    • +

      Immunotherapy and chemotherapy combinations

      09:00 - 09:20  |  Presenter: S. Ponce Aix

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Combination of immunotherapy with targeted therapies

      09:20 - 09:40  |  Presenter: L. Hendriks

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Combination of immunotherapies

      09:40 - 10:00  |  Presenter: S. Antonia

      • Abstract

      No abstract available for this presentation

    • +

      Combination of immunotherapy with radiation therapy

      10:00 - 10:20  |  Presenter: H. Choy

      • Abstract

      No abstract available for this presentation

    • +

      Q&A

      10:20 - 10:30

      • Abstract

      No abstract available for this presentation

  • +

    Mesothelioma: New roads through understanding biology

    • Type: Educational session
    • Presentations: 5
    • Moderators:A. Scherpereel
    • Coordinates: 4/13/2018, 09:00 - 10:30, Room C
  • +

    Next generation TKI: Frontline or later?

    • Type: Controversy session
    • Presentations: 4
    • Moderators:S. Ramalingam
    • Coordinates: 4/13/2018, 09:15 - 10:15, Room A
  • +

    Coffee break

    • Type: Coffee break
    • Presentations: 0
    • Coordinates: 4/13/2018, 10:30 - 11:00, Hall 1
  • +

    Immune checkpoint blockade: Basic mechanisms, preclinical evaluation and mechanisms of resistance

    • Type: Educational session
    • Presentations: 5
    • Moderators:O. Michielin
    • Coordinates: 4/13/2018, 11:00 - 12:30, Room C
    • +

      Cancer immunity and immune set point

      11:00 - 11:20  |  Presenter: D. Chen

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      The basics of immunology in lung cancer

      11:20 - 11:40  |  Presenter: L. Rivoltini

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Genomic background and immune landscape

      11:40 - 12:00  |  Presenter: F. Skoulidis

      • Abstract

      No abstract available for this presentation

    • +

      Mechanisms of resistance to immune checkpoint blockade

      12:00 - 12:20  |  Presenter: N. Bendriss-Vermare

      • Abstract

      No abstract available for this presentation

    • +

      Q&A

      12:20 - 12:30

      • Abstract

      No abstract available for this presentation

  • +

    New approaches in rare thoracic tumors

    • Type: Proffered Paper session
    • Presentations: 6
    • Moderators:M. Perol
    • Coordinates: 4/13/2018, 11:00 - 12:30, Room A
    • +

      135O - A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer

      11:00 - 11:15  |  Presenter: B. Besse

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Invited Discussant 135O

      11:15 - 11:25  |  Presenter: M. Perol

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      112O - Primary result of an investigator-initiated phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study (NCCH1505)

      11:25 - 11:40  |  Presenter: T. Seto

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      213O - Nintedanib + pemetrexed/cisplatin in malignant pleural mesothelioma (MPM): Phase II biomarker data from the LUME Meso study

      11:40 - 11:55  |  Presenter: N. Pavlakis

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      214O - Multiplexed proteomics biomarkers for malignant pleural mesothelioma detection in blood

      11:55 - 12:10  |  Presenter: F. Cerciello

      • Abstract

      Loading...

    • +

      Invited Discussant 112O, 213O and 214O

      12:10 - 12:30  |  Presenter: N. Girard

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.